Title:

Senior Director, New Product Strategy & Innovation

Company:

Ipsen Pharma (SAS)

Job Description:

At Ipsen, our vision is to be a leading global mid-size biopharmaceutical company, with a focus on transformative medicines in three key therapeutic areas: oncology, rare disease, and neuroscience.

A key strategic focus for us to meet this objective is the creation of a balanced and sustainable pipeline that drives commercial success through delivering value to patients’ lives.

The New Product Strategy & Innovation Team is responsible for leading the end-to-end process of setting the therapeutic area strategies, bringing in external assets with our global partnering colleagues, and establishing and implementing early commercialization and pre-launch plans to maximize asset value.

In the last 2-years we have brought in over 20 new assets into our pipeline, and looking forward we will continue to grow and advance this pipeline while launching products across therapeutic areas. As such, the New Product Strategy & Innovation team is expanding its capacity, capabilities, and responsibilities to ensure that we meet the overall objectives and vision of Ipsen’s growing portfolio for patients.

To support this vision, the Senior Director, New Product Strategy & Innovation role will directly contribute to:

• Evolution of the Therapeutic Area & Franchise Strategies

• Commercial leadership of external asset evaluations in strong collaboration with the Global Partnering & External Innovation Team

• Commercial leadership of all internal pipeline assets including early commercial phase 1-2 assets and pre-launch Ph 3 assets until transition to the in-line asset lead and brand team

MAIN RESPONSIBILITIES

 Support External Innovation / New Product / Portfolio Strategy:

• Lead and update the external innovation strategies across therapeutic areas and present recommendations to executive leadership

• Apply the therapeutic area strategies to the determination of external innovation and business development priorities

• Identify and implement opportunities to enhance the business development assessment process

• Work with regional and country brand leads as appropriate to capture relevant market knowledge and unmet needs

 Find & Evaluate New External / Business Development Opportunities:

• Represent commercial team and leadership in all business development and external innovation activities

• Be the commercial lead across all stages of the business development & external innovation process including sourcing, triage, business case development and due diligence 

• Survey the market for new opportunities and indications to support asset sourcing & triage

• Establish a strong external expert network in current and target disease areas to understand new asset potential and unmet needs

• Work with Global Partnering & External Innovation to seek out new opportunities proactively as well as providing detailed feedback on assets in triage

• Attend relevant external meetings e.g., academic congresses and business development forums to identify and capture new opportunities for Ipsen

• Lead in-depth commercial evaluation process (e.g., current & future landscaping, secondary and primary market research, forecasting, pricing & access assessment, SMM estimation, etc.) to inform commercial evaluation and diligence

• Be a proactive partner and work collaboratively with cross-functional teams (e.g., business development, external innovation, medical affairs, R&D, regulatory, finance, countries, global pricing & access, business excellence) to support inputs required for commercial modelling & business case development

• Ensure streamlined, efficient, and quality content generation across all evaluations aligning with internal processes

• Own & present New Product Strategy & Innovation recommendations to cross-functional team and executive leadership teams  

• Work closely with other counterparts across franchises to share best practices and business opportunities

Driving Internal Pipeline Value & Operationalization

• Commercial lead for integration of new assets across phases 1 – 3 into Ipsen pipeline

• Apply deal case assumptions to inform initial clinical trial developm